Motivation sphere features of patients with psychoendocrine syndrome on the background of hypogonadism

Main Article Content

V.V. Ischuk,
M.L. Kyryliuk


Background. Psychoneuroendocrinology is the clinical study of hormone fluctuations and their relationship to human behavior. It may be viewed from the perspective of psychiatry, where in certain mood disorders, there are associated neuroendocrine or hormonal changes affecting the brain. It may also be viewed from the perspective of endocrinology, where certain endocrine disorders can be associated with psychiatric illness. This complex blend of psychiatry, neurology and endocrinology is needed to comprehensively understand and treat psychiatric illnesses. The purpose of work was to determine particular motivational-volitional features of patients with psychoendocrine syndrome on the background of hypogonadism in 100 patients in Ukrainian Scientific-Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of Ministry of Health of Ukraine. Materials and methods. Patients were examined using the Buss — Durkee test (Buss — Durkee Hostility Inventory, A.H. Buss, A. Durkee, 1957, BDHI) and Plutchik impulsivity scale (Impulsiveness Scale, R. Plutchik, H. M. van Praag, 1989, IS). Results. The study defined a clinical-psychopathological structure of impulsivity in patients with psychoendocrine syndrome on the background of hypogonadism. In patients with moderate compensation hormonal status evasion-vicarious and disprosective correlates of impulsive behaviors prevail. In the decompensation state thymic labile and disretentive correlates prevail. Conclusions. It was found statistically significant predominance of the intensity of aggressive reaction forms among patients with hypogonadism in decompensated state (mediated by the phenomena of aggression, irritability, negativism, resentment, verbal aggression and guilt).

Article Details

How to Cite
Ischuk, V., and M. Kyryliuk. “Motivation Sphere Features of Patients With Psychoendocrine Syndrome on the Background of Hypogonadism”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 5, Oct. 2017, pp. 311-4, doi:10.22141/2224-0721.13.5.2017.110019.
Original Researches


Kozhina HM, Korostiy VI, Tovazhnianska OL, Grygorova IA, Litvin YeE. Clinical and neuropsychological features of cognitive disorders in patients with endocrine diseases. Ukrainskiy visnyk psykhonevrologii. 2012;20(70 Suppl):44. (in Ukrainian).

Kosenko NA, Tsygankov BD, Kosenko VH, Ageev MI, Krasil`nikov GT, Shebagina EF. Mental desorders in endocrinopathies. Kubanskiy nauchnyj meditsinskiy vestnik. 2014;6:107-14. (in Russian).

Luchytskyy EV, Luchytskyy VE, Tronko MD. Male hypogonadism (part 1). Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2017;13(4):281-9. doi: 10.22141/2224-0721.13.4.2017.106658. (in Ukrainian).

Uvarova EV, Trifonova EV. Hypogonadotropic hypogonadism (review). Pediatricheskaya farmakologiya. 2008;4:45-53. (in Russian).

Brambilla F. Psychopathological aspects of neuroendocrine diseases: Possible parallels with the psychoendocrine aspects of normal aging. Psychoneuroendocrinology. 1992 Aug;17(4):283-91. doi: 10.1016/0306-4530(92)90035-6.

Geffken GR, Ward HE, Staab JP, et al. Psychiatric morbidity in endocrine disorders. Psychiatr Clin North Am. 1998 Jun;21(2):473-89. PMID: 9670238.

Kumar P, Kumar N, Thakur DS, Patidar A. Male hypogonadism: Symptoms and treatment. J Adv Pharm Technol Res. 2010 Jul;1(3):297-301. doi: 10.4103/0110-5558.72420.

Salenave S, Trabado S, Maione L, Brailly-Tabard S, Young J. Male acquired hypogonadotropic hypogonadism: diagnosis and treatment. Ann Endocrinol (Paris). 2012 Apr;73(2):141-6. doi: 10.1016/j.ando.2012.03.040.

Wang C, Swedloff RS, Iranmanesh A, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53. doi: 10.1210/jcem.85.8.6747.

Most read articles by the same author(s)